Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Fluticasone Propionate 1%/Loratadine 2% Topical Gel is a semisolid formulation, dispensed through a pump mechanism for easy and precise application. This compounded medication is designed for targeted treatment of Allergic Rhinitis, Atopic Dermatitis, Eczema, Urticaria, and Pruritus, delivering active ingredients directly to the skin in a gel-like consistency.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present our compounded formulation of Fluticasone Propionate 1%/Loratadine 2% in a unique topical gel format. This innovative formulation is specifically designed to address a range of skin conditions, including eczema, psoriasis, and contact dermatitis. The synergistic combination of Fluticasone Propionate and Loratadine offers potent anti-inflammatory and anti-allergic properties, effectively alleviating symptoms such as itching, redness, and swelling.
The Fluticasone Propionate 1%/Loratadine 2% Topical Gel is a semisolid formulation dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment. The gel-like consistency ensures optimal absorption of the active ingredients. It can be applied up to twice daily for maximum effect. However, it is crucial to avoid application on the face to prevent potential irritation. Also, avoid contact with the eyes and mouth.
For those considering this formulation, it is essential to understand that it should not be used for more than two weeks without a physician's consultation. Regular monitoring for any signs of adverse reactions, such as skin irritation, burning, or itching, is also recommended.
At Bayview Pharmacy, our team of dedicated compounding pharmacists is committed to delivering the highest standard of care and service. We are here to answer any questions or concerns you may have about the Fluticasone Propionate 1%/Loratadine 2% Topical Gel. Your health and well-being are our top priority.
Fluticasone Propionate 1%/Loratadine 2% Topical Gel is a compounded formulation designed for the treatment of allergic rhinitis, atopic dermatitis, and other allergic skin conditions. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients.
It is crucial to note that this formulation should not be used by patients with known hypersensitivity to either fluticasone propionate or loratadine. It is also contraindicated in patients with a history of glaucoma or cataracts. If you have any of these conditions, please consult with your healthcare provider before using this product.
When using this formulation, patients should monitor for signs of local irritation, such as redness, itching, burning, or stinging. If these symptoms occur, discontinue use immediately and contact your healthcare provider. It is also advised to avoid contact with the eyes, as this may cause irritation.
Patients should use this formulation as directed by their healthcare provider. For allergic rhinitis, the gel should be applied to the affected area twice daily. For atopic dermatitis, the gel should be applied to the affected area once daily. It is important to follow these directions to ensure the effectiveness of the treatment.
This formulation should not be used in combination with other topical corticosteroids or antihistamines. If you have any questions or concerns about the use of this formulation, please consult with your healthcare provider. It is important to use this product responsibly and under the guidance of a healthcare professional.
Fluticasone Propionate 1%/Loratadine 2% Topical Gel is a compounded formulation designed to treat various skin conditions such as eczema, psoriasis, and contact dermatitis. This unique combination of Fluticasone Propionate, a corticosteroid, and Loratadine, an antihistamine, works synergistically to alleviate inflammation, itching, redness, and swelling associated with these skin conditions.
The gel is dispensed through a pump mechanism, which allows for easy and precise application. To use, apply a thin layer of the gel to the affected skin area twice daily or as directed by your healthcare provider. The gel should be gently rubbed into the skin until it is fully absorbed. Avoid covering the treated area with a bandage or other covering unless specifically instructed by your healthcare provider. It is crucial to wash your hands thoroughly after applying the gel to prevent accidental ingestion or spreading to other areas.
Adherence to the prescribed dosage is vital for the effectiveness of this medication. Do not alter the amount used or the frequency of application without consulting your healthcare provider. Overuse may increase the risk of potential side effects. If you experience any adverse reactions such as burning, stinging, or increased redness, it is important to contact your healthcare provider immediately.
If you have any queries or concerns regarding the use of Fluticasone Propionate 1%/Loratadine 2% Topical Gel, do not hesitate to seek advice. It is always important to have a clear understanding of how to use your medication to ensure its maximum effectiveness and your safety.
This is a compounded formulation that combines Fluticasone Propionate and Loratadine in a gel form. It is designed to be applied topically on the skin for targeted treatment.
This formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The gel has a semisolid formulation, which means it has a gel-like consistency that is easy to apply and spread on the skin.
The active ingredients in this formulation are Fluticasone Propionate, a corticosteroid that reduces inflammation, and Loratadine, an antihistamine that reduces allergic reactions.
You should apply this gel directly to the affected area of the skin as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
This gel is typically used for skin conditions that respond to the anti-inflammatory and antihistamine properties of Fluticasone Propionate and Loratadine. However, it should only be used as directed by a healthcare provider.
As with any medication, there can be side effects. These may include skin irritation or dryness. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
If you are pregnant or breastfeeding, you should consult your healthcare provider before using this gel. They will be able to advise you on whether it is safe for you to use.
This gel should be stored at room temperature, away from heat and direct light. Do not freeze. Keep out of reach of children and pets.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
